# BCB Bancorp Inc: financial statements, quarterly

BCBP · Nasdaq · CIK 1228454 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcbp.md) · [Financials](/companies/bcbp/financials.md) · [Filings](/companies/bcbp/filings.md) · [Insiders](/companies/bcbp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcbp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [23.4](/filings/0001228454-24-000012.md) | [25.8 d](/filings/0001228454-24-000003.md) | [26.1](/filings/0001228454-24-000006.md) | [25.8](/filings/0001228454-24-000009.md) | [25.6](/filings/0001228454-24-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.7](/filings/0001228454-25-000015.md) | [2.6 d](/filings/0001228454-26-000004.md) | [2.5](/filings/0001228454-26-000006.md) | [1.2](/filings/0001228454-26-000008.md) | [2.7](/filings/0001228454-25-000015.md) | [1.3 d](/filings/0001228454-26-000004.md) | [(3.4)](/filings/0001228454-26-000006.md) | [1.5](/filings/0001228454-26-000008.md) | [1.5](/filings/0001228454-25-000015.md) | [(5.4) d](/filings/0001228454-26-000004.md) | [1.7](/filings/0001228454-26-000006.md) | [(3.5)](/filings/0001228454-26-000008.md) |
| Net income | $m | [6.7](/filings/0001228454-25-000015.md) | [6.1 d](/filings/0001228454-26-000004.md) | [5.9](/filings/0001228454-26-000006.md) | [2.8](/filings/0001228454-26-000008.md) | [6.7](/filings/0001228454-25-000015.md) | [3.3 d](/filings/0001228454-26-000004.md) | [(8.3)](/filings/0001228454-26-000006.md) | [3.6](/filings/0001228454-26-000008.md) | [4.3](/filings/0001228454-25-000015.md) | [(12.0) d](/filings/0001228454-26-000004.md) | [4.9](/filings/0001228454-26-000006.md) | [(14.8)](/filings/0001228454-26-000008.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001228454-25-000015.md) | not reported | [0.32](/filings/0001228454-26-000006.md) | [0.14](/filings/0001228454-26-000008.md) | [0.36](/filings/0001228454-25-000015.md) | not reported | [(0.51)](/filings/0001228454-26-000006.md) | [0.18](/filings/0001228454-26-000008.md) | [0.22](/filings/0001228454-25-000015.md) | not reported | [0.26](/filings/0001228454-26-000006.md) | [(0.85)](/filings/0001228454-26-000008.md) |
| Basic EPS | $ per share | [0.39](/filings/0001228454-25-000015.md) | not reported | [0.32](/filings/0001228454-26-000006.md) | [0.14](/filings/0001228454-26-000008.md) | [0.36](/filings/0001228454-25-000015.md) | not reported | [(0.51)](/filings/0001228454-26-000006.md) | [0.18](/filings/0001228454-26-000008.md) | [0.22](/filings/0001228454-25-000015.md) | not reported | [0.26](/filings/0001228454-26-000006.md) | [(0.85)](/filings/0001228454-26-000008.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,812](/filings/0001228454-23-000015.md) | [3,832](/filings/0001228454-25-000003.md) | [3,849](/filings/0001228454-24-000006.md) | [3,794](/filings/0001228454-24-000009.md) | [3,614](/filings/0001228454-24-000012.md) | [3,599](/filings/0001228454-26-000004.md) | [3,474](/filings/0001228454-25-000007.md) | [3,380](/filings/0001228454-25-000011.md) | [3,353](/filings/0001228454-25-000015.md) | [3,279](/filings/0001228454-26-000008.md) | [3,269](/filings/0001228454-26-000006.md) | [3,118](/filings/0001228454-26-000008.md) |
| Total liabilities | $m | [3,508](/filings/0001228454-23-000015.md) | [3,518](/filings/0001228454-25-000003.md) | [3,529](/filings/0001228454-24-000006.md) | [3,473](/filings/0001228454-24-000009.md) | [3,286](/filings/0001228454-24-000012.md) | [3,275](/filings/0001228454-26-000004.md) | [3,159](/filings/0001228454-25-000007.md) | [3,065](/filings/0001228454-25-000011.md) | [3,035](/filings/0001228454-25-000015.md) | [2,975](/filings/0001228454-26-000008.md) | [2,962](/filings/0001228454-26-000006.md) | [2,826](/filings/0001228454-26-000008.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [304](/filings/0001228454-25-000015.md) | [314](/filings/0001228454-26-000008.md) | [320](/filings/0001228454-26-000008.md) | [321](/filings/0001228454-26-000008.md) | [328](/filings/0001228454-25-000015.md) | [324](/filings/0001228454-26-000008.md) | [315](/filings/0001228454-26-000008.md) | [316](/filings/0001228454-26-000008.md) | [318](/filings/0001228454-25-000015.md) | [304](/filings/0001228454-26-000008.md) | [307](/filings/0001228454-26-000008.md) | [292](/filings/0001228454-26-000008.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.0 d](/filings/0001228454-25-000015.md) | [0.7 d](/filings/0001228454-26-000004.md) | [8.3](/filings/0001228454-26-000006.md) | [8.1 d](/filings/0001228454-26-000008.md) | [43.5 d](/filings/0001228454-25-000015.md) | [7.8 d](/filings/0001228454-26-000004.md) | [5.0](/filings/0001228454-26-000006.md) | [10.3 d](/filings/0001228454-26-000008.md) | [8.7 d](/filings/0001228454-25-000015.md) | [11.8 d](/filings/0001228454-26-000004.md) | [5.2](/filings/0001228454-26-000006.md) | [9.6 d](/filings/0001228454-26-000008.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001228454-25-000015.md) | [0.2 d](/filings/0001228454-26-000004.md) | [0.1](/filings/0001228454-26-000006.md) | [0.0 d](/filings/0001228454-26-000008.md) | [0.1 d](/filings/0001228454-25-000015.md) | [1.0 d](/filings/0001228454-26-000004.md) | [0.3](/filings/0001228454-26-000006.md) | [0.2 d](/filings/0001228454-26-000008.md) | [0.3 d](/filings/0001228454-25-000015.md) | [0.3 d](/filings/0001228454-26-000004.md) | [0.3](/filings/0001228454-26-000006.md) | [0.2 d](/filings/0001228454-26-000008.md) |
| Dividends paid | $m | [2.6 d](/filings/0001228454-25-000015.md) | [2.6 d](/filings/0001228454-26-000004.md) | [2.6](/filings/0001228454-26-000006.md) | [2.6 d](/filings/0001228454-26-000008.md) | [2.6 d](/filings/0001228454-25-000015.md) | [2.6 d](/filings/0001228454-26-000004.md) | [2.7](/filings/0001228454-26-000006.md) | [2.7 d](/filings/0001228454-26-000008.md) | [2.6 d](/filings/0001228454-25-000015.md) | [2.6 d](/filings/0001228454-26-000004.md) | [1.4](/filings/0001228454-26-000006.md) | [1.4 d](/filings/0001228454-26-000008.md) |
| Share repurchases | $m | [0.0 d](/filings/0001228454-25-000015.md) | [0.0 d](/filings/0001228454-26-000004.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.4](/filings/0001228454-24-000012.md) | [17.2](/filings/0001228454-25-000007.md) | [16.8](/filings/0001228454-25-000011.md) | [16.9](/filings/0001228454-25-000015.md) | [16.9](/filings/0001228454-26-000006.md) | [17.0](/filings/0001228454-26-000008.md) | [17.1](/filings/0001228454-25-000015.md) | [17.1](/filings/0001228454-26-000006.md) | [17.2](/filings/0001228454-26-000008.md) | [17.2](/filings/0001228454-25-000015.md) | [17.3](/filings/0001228454-26-000006.md) | [17.3](/filings/0001228454-26-000008.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,101,822 at 2026-08-01, from the cover of the [10-Q filed 2026-08-10](/filings/0001228454-26-000008.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.